Key Metrics
52.7
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.01 - 0.05
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
>= 25
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.94
5-Year SI
5-year SI
- 0.95 2-year SI
- 0.93 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Oncology
SJR
- Q1 Oncology
- Q1 Cancer Research
- Q1 Molecular Medicine
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
5.2
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
20%
4 to 6 months
60%
7 to 9 months
15%
Above 9 months
5%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
DOAJ -
SJR
Topics Covered
- Cancer
- Carcinogenesis
- Antigen
- Lung cancer
- Tumor microenvironment
- Hepatocellular carcinoma
- RNA editing
- Breast cancer
- Immunotherapy
- Extracellular vesicles
- Metabolic reprogramming
- DNA damage
- Host gene
- Therapeutic effect
- Tumor growth
- Tyrosine kinase
- Renal carcinoma
- Vasculogenic mimicry
- Colorectal cancer
- Cancer development
Journal Specifications
| Overview | |
| Publisher | BMC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 3990 | USD 4890 | GBP 3490 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2002 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 16 |
| Article Processing Charges | EUR 3990 | USD 4890 | GBP 3490 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC0 |
| OA statement | Visit website |
Planning to publish in Molecular Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Uncovering the predictive and immunomodulatory potential of transient receptor potential melastatin family-related CCNE1 in pan-cancer
- 18 Nov 24
- Molecular Cancer
-
Full paper
Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope.
- 15 Nov 24
- Molecular cancer
-
Full paper
Single-cell and spatial transcriptomics identify COL6A3 as a prognostic biomarker in undifferentiated pleomorphic sarcoma.
- 15 Nov 24
- Molecular cancer
-
Full paper
Clinical advances and challenges in targeting FGF/FGFR signaling in lung cancer.
- 15 Nov 24
- Molecular cancer
-
Full paper
Immune dynamics shaping pre-metastatic and metastatic niches in liver metastases: from molecular mechanisms to therapeutic strategies.
- 14 Nov 24
- Molecular cancer
-
Full paper
The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRASG12D-driven non-small cell lung cancer.
- 12 Nov 24
- Molecular cancer
Scite analysis
Powered by scite_
3.4k articles received 219.5k citations see all
- 7,008 Supporting
- 210,455 Mentioning
- 517 Contrasting
Editorial notices
- 60 Retractions
- 0 Withdrawals
- 112 Corrections
- 84 Errata
- 3 Expression of Concern
FAQs
How long has Molecular Cancer been actively publishing?
Molecular Cancer has been in operation since 2002 till date.
What is the publishing frequency of Molecular Cancer ?
Molecular Cancer published with a Continuous publication frequency.
How many articles did Molecular Cancer publish last years ?
In 2023, Molecular Cancer published 209 articles.
What is the eISSN & pISSN for Molecular Cancer ?
For Molecular Cancer,eISSN is 1476-4598 and pISSN is1476-4598.
What is Citescore for Molecular Cancer ?
Citescore for Molecular Cancer is 52.7.
What is SNIP score for Molecular Cancer ?
SNIP score for Molecular Cancer is 5.2.
What is the SJR for Molecular Cancer ?
SJR for Molecular Cancer is Q1.
Who is the publisher of Molecular Cancer ?
BMC is the publisher of Molecular Cancer.